Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) EBT (2010 - 2026)

Palatin Technologies' (PTN) quarterly EBT came in at -$1.4 million in Q1 2026, up 70.04% on a YoY basis from -$842719.1 in Q1 2025, and up 80.27% quarter-over-quarter from -$7.3 million in Q4 2025.

Analysis

Palatin Technologies (PTN) EBT (2010 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported EBT for 17 consecutive years, with -$1.4 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, EBT rose 70.04% year-over-year to -$1.4 million; the trailing twelve-month figure through Mar 2026 stood at -$6.3 million (up 73.13% YoY), and the FY2025 full-year result was -$17.3 million, up 41.8% from the prior year.
  • EBT advanced to -$1.4 million in Q1 2026 per PTN's latest filing, from -$7.3 million in the prior quarter.
  • Across five years, EBT topped out at $4.7 million in Q3 2025 and bottomed at -$12.8 million in Q2 2022.
  • Historically, EBT has averaged -$6.0 million across 5 years, with a median of -$7.6 million in 2022.
  • The sharpest annual moves came in 2022 and 2025: EBT slumped 558.58% in 2022, then soared 160.81% in 2025.
  • Over 5 years, EBT stood at -$2.0 million in 2022, then tumbled by 298.67% to -$7.8 million in 2023, then jumped by 67.03% to -$2.6 million in 2024, then slumped by 180.88% to -$7.3 million in 2025, then surged by 80.27% to -$1.4 million in 2026.
  • According to Business Quant data, EBT over the past three periods registered -$1.4 million, -$7.3 million, and $4.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 2.77 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -10.25 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 1.39 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 1.53 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 542.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -767.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 177.81 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 132.40 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -294.56 Mn
10 Palatin Technologies 46.98 Mn 46.98 Mn - -1.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.43 Mn
Dec 31, 2025 -7.26 Mn
Sep 30, 2025 4.68 Mn
Jun 30, 2025 -2.25 Mn
Mar 31, 2025 -4.78 Mn
Dec 31, 2024 -2.59 Mn
Sep 30, 2024 -7.69 Mn
Jun 30, 2024 -8.25 Mn
Mar 31, 2024 -8.44 Mn
Dec 31, 2023 -7.84 Mn
Sep 30, 2023 -6.05 Mn
Jun 30, 2023 -9.82 Mn
Mar 31, 2023 -8.67 Mn
Dec 31, 2022 -1.97 Mn
Sep 30, 2022 -8.67 Mn
Jun 30, 2022 -12.77 Mn
Mar 31, 2022 -7.63 Mn
Dec 31, 2021 -8.69 Mn
Sep 30, 2021 -7.22 Mn
Jun 30, 2021 2.78 Mn